Since 1995, Equinox Group has provided analytics to support R&D decisions at pharmaceutical firms in over 1,000 projects, assessing the potential of drugs from discovery to launch, and anywhere in between. Our validated techniques will save our clients' time and money, as well as overcome the deficiencies of traditional market research.

Our specialties include:
• Assessing the value of drugs in R&D
• Disease-area strategy
• Indication prioritization
• Supporting business development assessments
• Market access
• Patient share forecasting
• Epidemiology & patient flow modeling


We have evaluated thousands of drug profiles across hundreds of indications in oncology, immunology, rare diseases, cardio-metabolic disorders, infectious diseases, neurology, respiratory, urology, ophthalmology, and endocrine disorders. We also have tailored methods to solve the unique analytical challenges that arise in oncology and rare diseases.

Equinox Group

David Godolphin

This department specializes in providing expert guidance and solutions to clients across various industries.

Consulting Services

This department focuses on high-level strategic decision-making and governance within the organization.

Executive Leadership

This department conducts scientific investigations and analyses to generate new knowledge and insights.

Equinox Group

Org chart

Teams

Consulting Services

Executive Leadership

Research Division

Offices

Equinox Group

Org chart

Teams

Consulting Services

Executive Leadership

Research Division

Offices

Related companies